Open AccessA Review of the Potential of Hemoperfusion for the Treatment of Patients with Respiratory Infectious Diseases with COVID-19 Approach
Author(s) -
Mohammadreza Moshari,
Mehrdad Mesbah Kiaei,
Mohammad Hassani
Publication year - 2021
Publication title -
archives of anesthesiology and critical care
Language(s) - English
Resource type - Journals
ISSN - 2423-5849
DOI - 10.18502/aacc.v7i3.6906
Subject(s) - hemoperfusion , covid-19 , disease , medicine , intensive care medicine , cytokine storm , infectious disease (medical specialty) , respiratory failure , immune system , immunology , hemodialysis
Severe infection with COVID-19 disease can be associated with respiratory failure, kidney disorders, and in more advanced stages, organ failure and death. Unfortunately, there is currently no definitive cure for this disease, and damage to the immune system caused by inflammatory storms leads to widespread and varied complications that make an early diagnosis of the disease difficult. Therefore, eliminating or inhibiting the production of factors involved in inflammatory storms can be effective in improving the clinical condition of patients. According to specialized studies on the role of hemoperfusion in inhibiting advanced levels of COVID-19 disease, the present study was performed to investigate the use of hemoperfusion as a potential treatment option for this disease.